Observatory of Patients With Metastatic ProstAte Adenocarcinoma That is Resistant to Castration and Multi-LinE Strategies
Condition(s):Metastatic Prostate AdenocarcinomaLast Updated:November 6, 2019Recruiting
Hide Studies Not Open or Pending
Condition(s):Metastatic Prostate AdenocarcinomaLast Updated:November 6, 2019Recruiting
Condition(s):Prostate CancerLast Updated:November 25, 2015Completed
Condition(s):Metastatic Prostatic AdenocarcinomaLast Updated:June 21, 2022Completed
Condition(s):Prostate CancerLast Updated:November 25, 2015Completed
Condition(s):Metastatic Prostatic AdenocarcinomaLast Updated:January 17, 2024Active, not recruiting
Condition(s):Prostate CancerLast Updated:March 22, 2024Active, not recruiting
Condition(s):Metastatic Prostate AdenocarcinomaLast Updated:September 22, 2022Completed
Condition(s):Prostatic Neoplasms; Castration-ResistantLast Updated:November 3, 2023Recruiting
Condition(s):Metastatic Prostate Adenocarcinoma; Stage IV Prostate Cancer AJCC v8Last Updated:August 7, 2023Recruiting
Condition(s):Prostate Cancer; Metastatic Prostate AdenocarcinomaLast Updated:October 19, 2022Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.